-
-
-
-
-
-
-
Kyverna Therapeutics (KYTX) to Present Data on 50 Patient Experience at Symposium at EULAR 2024
-
-
-
-
-
-
-
Geron Corp (GERN) Announces FDA Approval of RYTELO
-
-
-
-
-
-
-
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
-
-
-
-
-
-
-
Ocuphire Pharma (OCUP) Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June
-
-
-
-
-
-
-
Lexaria Bioscience (LEXX): Dosing Continues in Lexaria’s Second GLP-1 Human Pilot Study
-
-
-
-
-
-
-
Precision BioSciences (DTIL) Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver Congress
-
-
-
-
-
-
-
Vir Biotechnology (VIR) Reports Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization
-
67,341 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.